RAFAEL HOLDINGS, INC. Interest Receivable, Current
RAFAEL HOLDINGS, INC. (RFL) had Interest Receivable, Current of $438.00 thousand as of 2024-10-31, per its 10-Q filed 2024-12-11.
Financial Statements › Notes › Nontrade Receivables
us-gaap:InterestReceivableCurrent · last filed 2025-10-29
- 2024-10-31: Interest Receivable, Current $438.00K.
- 2024-07-31: Interest Receivable, Current $515.00K.
- 2024-04-30: Interest Receivable, Current $541.00K.
- 2024-01-31: Interest Receivable, Current $560.00K.
| Period end | Interest Receivable, Current |
|---|---|
| 2024-10-31 | $438.00K 10-Q · filed 2024-12-11 |
| 2024-07-31 | $515.00K 10-K · filed 2025-10-29 |
| 2024-04-30 | $541.00K 10-Q · filed 2024-06-14 |
| 2024-01-31 | $560.00K 10-Q · filed 2024-03-14 |
| 2023-10-31 | $420.00K 10-Q · filed 2023-12-14 |
| 2023-07-31 | $387.00K 10-K/A · filed 2024-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |